William A. Blattner

Active 1982–2020

Also published as
WILLIAM A. BLATTNER
87
Papers
19,361
Citations
77
h-index
87
i10-index

Citations

Citations per year for William A. Blattner1944: 1 citations1982: 5 citations1983: 64 citations1984: 83 citations1985: 66 citations1986: 56 citations1987: 92 citations1988: 83 citations1989: 59 citations1990: 74 citations1991: 100 citations1992: 116 citations1993: 115 citations1994: 91 citations1995: 79 citations1996: 67 citations1997: 76 citations1998: 62 citations1999: 78 citations2000: 90 citations2001: 74 citations2002: 82 citations2003: 72 citations2004: 97 citations2005: 91 citations2006: 72 citations2007: 80 citations2008: 71 citations2009: 125 citations2010: 126 citations2011: 146 citations2012: 136 citations2013: 119 citations2014: 101 citations2015: 80 citations2016: 83 citations2017: 64 citations2018: 48 citations2019: 267 citations2020: 240 citations2021: 163 citations2022: 121 citations2023: 80 citations2024: 102 citations2025: 42 citations1945–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,280 citing papers, 40.9% of this breakdownUnited Kingdom: 468 citing papers, 8.4% of this breakdownFrance: 253 citing papers, 4.5% of this breakdownCanada: 200 citing papers, 3.6% of this breakdownSouth Africa: 172 citing papers, 3.1% of this breakdownAustralia: 143 citing papers, 2.5% of this breakdownGermany: 140 citing papers, 2.5% of this breakdownJapan: 139 citing papers, 2.5% of this breakdownNetherlands: 138 citing papers, 2.5% of this breakdownItaly: 132 citing papers, 2.4% of this breakdownNigeria: 105 citing papers, 1.9% of this breakdownBrazil: 93 citing papers, 1.7% of this breakdown
0%40.9%Other 23.5%

Fields

  • Immunology and Microbiology46.3%
  • Medicine40.7%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Social Sciences0.6%
  • Health Professions0.6%
  • Environmental Science0.4%
  • Other2.3%

Topics

  • HIV Research and Treatment12.3%
  • HIV/AIDS Research and Interventions6.7%
  • T-cell and Retrovirus Studies5.1%
  • Immune Cell Function and Interaction4.9%
  • HIV/AIDS drug development and treatment3.9%
  • Cancer-related Molecular Pathways3.9%
  • Other63.2%

Coauthors

All papers

Open in search
  1. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natasha T. Wood, Cathal Seoighe, Alan S. Perelson, Tanmoy Bhattacharya, Bette Korber, Beatrice H. Hahn, George M. Shaw - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 1,937

  2. Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Virology 2008 cited by 624

  3. A cancer family syndrome in twenty-four kindreds.

    Authors: , , , , , , - 1988 cited by 1,285

  4. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome

    Authors: , , , , - Nature 1990 cited by 1,219

  5. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection

    Authors: , , , , , , , , , , , , , , - Nature Medicine 1996 cited by 966

  6. Cancer incidence in Nigeria: A report from population-based cancer registries

    Authors: , , , , , , , , , , , , , - Cancer Epidemiology 2012 cited by 391

  7. Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults

    Authors: , , , , , , , , , , , , , , , , - PLoS ONE 2012 cited by 111

  8. The immediate effect of the Same-Sex Marriage Prohibition Act on stigma, discrimination, and engagement on HIV prevention and treatment services in men who have sex with men in Nigeria: analysis of prospective data from the TRUST cohort

    Authors: , , , , , , , , , - The Lancet HIV 2015 cited by 245

  9. Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2011 cited by 177

  10. Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria

    Authors: , , , , , , - PLoS ONE 2013 cited by 108

  11. Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Craig A. Magaret, William R. Schief, Yih‐En Andrew Ban, Ming Zhang, Kelly A. Soderberg, Joseph Sodroski, Barton F. Haynes, George M. Shaw, Beatrice H. Hahn, Bette Korber - PLoS Pathogens 2011 cited by 125

  12. Elevated Plasma Levels of sCD14 and MCP-1 Are Associated With HIV Associated Neurocognitive Disorders Among Antiretroviral-Naive Individuals in Nigeria

    Authors: , , , , , , , , , , , , - JAIDS Journal of Acquired Immune Deficiency Syndromes 2020 cited by 25

  13. Infective dermatitis of Jamaican children: a marker for HTLV-I infection

    Authors: , , , , - The Lancet 1990 cited by 456

  14. Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden

    Authors: , , , , , , , , , , - International Journal of Cancer 1997 cited by 299

  15. The Effects of Cigarette Smoking on T Cell Subsets: A Population-based Survey of Healthy Caucasians

    Authors: , , , , , , , - American Review of Respiratory Disease 1989 cited by 190

  16. High prevalence of HIV, chlamydia and gonorrhoea among men who have sex with men and transgender women attending trusted community centres in Abuja and Lagos, Nigeria

    Authors: , , , , , , , , , , , , , , , , - Journal of the International AIDS Society 2016 cited by 143

  17. Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors

    Authors: , , , , , , , , , , , , , , , , - PLoS ONE 2010 cited by 139

  18. Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

    Authors: , , , , , , , , , , , , , , , , , , - Vaccine 2006 cited by 93

  19. Stigma, access to healthcare, and HIV risks among men who sell sex to men in Nigeria

    Authors: , , , , , , , , , , - Journal of the International AIDS Society 2017 cited by 80

  20. Reversal of Human Immunodeficiency Virus Type 1 IIIB to a Neutralization-Resistant Phenotype in an Accidentally Infected Laboratory Worker with a Progressive Clinical Course

    Authors: , , , , , - Journal of Virology 2001 cited by 76

  21. Immune status, and not HIV infection or exposure, drives the development of the oral microbiota

    Authors: , , , , , , , , , , - Scientific Reports 2020 cited by 31

  22. The human type‐C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T‐cell leukemia/lymphoma

    Authors: , , , , , , , , , - International Journal of Cancer 1982 cited by 578

  23. Sexual Transmission of Human T-Lymphotropic Virus Type I (HTLV-I)

    Authors: , , , , , , , , - Annals of Internal Medicine 1989 cited by 256

  24. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States

    Authors: , , , , , , - The American Journal of Surgical Pathology 1984 cited by 210